Showing results (851-860 of 954) with videos related to
Sort By:
Pageof 96
Clinical & Developmental Immunology|November 30, 2013
Induction of Th17 lymphocytes and Treg cells by monocyte-derived dendritic cells in patients with rheumatoid arthritis and systemic lupus erythematosusLizbeth Estrada-Capetillo, Berenice Hernández-Castro, Adriana Monsiváis-Urenda, et al.Clinical & Developmental Immunology|November 30, 2013
BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitisSofia Fernanda Gonçalves Zorzella-Pezavento, Clara Pires Fujiara Guerino, Fernanda Chiuso-Minicucci, et al.Clinical & Developmental Immunology|November 14, 2013
Late and chronic antibody-mediated rejection: main barrier to long term graft survivalQiquan Sun, Yang YangClinical & Developmental Immunology|November 14, 2013
T helper 17 cells in autoimmune liver diseasesMasanori Abe, Yoichi Hiasa, Morikazu OnjiClinical & Developmental Immunology|November 14, 2013
The -174G/C and -572G/C interleukin 6 promoter gene polymorphisms in mexican patients with rheumatoid arthritis: a case-control studyS A Zavaleta-Muñiz, B T Martín-Márquez, L Gonzalez-Lopez, et al.Clinical & Developmental Immunology|April 24, 2010
Interleukin-15 affects patient survival through natural killer cell recovery after autologous hematopoietic stem cell transplantation for non-Hodgkin lymphomasLuis F Porrata, David J Inwards, Ivana N Micallef, et al.Clinical & Developmental Immunology|September 24, 2011
Systemic lupus erythematosus and systemic autoimmune connective tissue disorders behind recurrent diastolic heart failureLuis Miguel Blasco Mata, Olga Acha Salazar, Carmen Rosa González-Fernández, et al.Clinical & Developmental Immunology|September 24, 2011
Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functionsChary López-Pedrera, Carlos Pérez-Sánchez, Manuel Ramos-Casals, et al.Clinical & Developmental Immunology|December 23, 2011
Patients with multiple myeloma develop SOX2-specific autoantibodies after allogeneic stem cell transplantationSebastian Kobold, Sinje Tams, Tim Luetkens, et al.Clinical & Developmental Immunology|December 23, 2011
Interferon lambda: a new sword in cancer immunotherapyAhmed Lasfar, Walid Abushahba, Murugabaskar Balan, et al.Pageof 96